SPARTAN RX CYP2C19 TEST SYSTEM
Aug 2013
237d
Spartan Bioscience, Inc. has submitted 1 FDA 510(k) premarket notifications since 2013, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Drug Metabolizing Enzyme Genotyping Systems . Use the specialty filter in the sidebar to narrow results.